BREAKING
Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 1 hour ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 1 hour ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 2 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 2 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 3 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 3 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 3 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 3 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 5 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 6 hours ago Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 1 hour ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 1 hour ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 2 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 2 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 3 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 3 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 3 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 3 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 5 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 6 hours ago
ADVERTISEMENT
Breaking News

BKNG Stock Plunges 7.65% to $3,925.75 Despite Beating Q4 Earnings Estimates

BKNG plunges 7.65% to $3,925.75 despite beating Q4 EPS estimates by 0.27%, extending losses to 25.8% from January highs on investor concerns about slowing growth.

February 19, 2026 2 min read
BKNG price 30d chart

BKNG plunges 7.65% to $3,925.75 despite beating Q4 EPS estimates by 0.27%, extending losses to 25.8% from January highs on investor concerns about slowing growth.

Stock Price
$3925.75
current
Change
-7.65%
today
Volume
141.1K
shares traded

Volume tells a troubling story. Today’s 141,133 shares traded represents just 30% of the recent average daily volume, suggesting the decline came on relatively thin participation. More concerning: the stock has traded in elevated volume every day since February 3, when it first broke down below $5,000 on 634,000 shares—nearly 3x normal volume.

Valuation disconnect widens. At current prices, BKNG trades at 12.5x forward earnings versus a trailing P/E of 25.5x, implying the market expects 2026 EPS of $312.99. Yet analysts maintain a $6,040 price target—54% above current levels—and a consensus “buy” rating. The company’s 19.4% profit margin and 44.9% operating margin remain industry-leading, but revenue growth of 12.7% may be slowing from post-pandemic peaks.

Technical damage compounds fundamental doubts. The travel services sector faces mounting headwinds as consumer spending signals weaken across discretionary categories. BKNG’s inability to hold gains even after beating estimates suggests investors are pricing in deceleration ahead. The $3,890 low established today now becomes critical support—a break below could trigger stops toward the $3,600-3,700 zone.

What to Watch: The next earnings report drops April 28, with analysts projecting Q1 2026 EPS of $29.08. Any guidance cut on that call could send shares below $3,500, while a return above the $4,250-4,300 resistance zone would signal the worst may be over.

This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.

ADVERTISEMENT